General Information of Drug Off-Target (DOT) (ID: OTO7O557)

DOT Name Histone-arginine methyltransferase METTL23 (METTL23)
Synonyms EC 2.1.1.319; Methyltransferase-like protein 23
Gene Name METTL23
Related Disease
Intellectual disability, autosomal recessive 44 ( )
Intellectual disability ( )
Autosomal recessive non-syndromic intellectual disability ( )
UniProt ID
MET23_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
2.1.1.319
Pfam ID
PF10294
Sequence
MYVWPCAVVLAQYLWFHRRSLPGKAILEIGAGVSLPGILAAKCGAEVILSDSSELPHCLE
VCRQSCQMNNLPHLQVVGLTWGHISWDLLALPPQDIILASDVFFEPEDFEDILATIYFLM
HKNPKVQLWSTYQVRSADWSLEALLYKWDMKCVHIPLESFDADKEDIAESTLPGRHTVEM
LVISFAKDSL
Function
Histone methyltransferase that dimethylates histone H3 at 'Arg-17', forming asymmetric dimethylarginine (H3R17me2a), leading to activate transcription via chromatin remodeling. Maternal factor involved in epigenetic chromatin reprogramming of the paternal genome in the zygote: mediates H3R17me2a, promoting histone H3.3 incorporation in the male pronucleus, leading to TET3 recruitment and subsequent DNA demethylation.
Reactome Pathway
Replacement of protamines by nucleosomes in the male pronucleus (R-HSA-9821993 )
Chromatin modifications during the maternal to zygotic transition (MZT) (R-HSA-9821002 )

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Intellectual disability, autosomal recessive 44 DIS0WEIX Strong Autosomal recessive [1]
Intellectual disability DISMBNXP moderate Genetic Variation [2]
Autosomal recessive non-syndromic intellectual disability DISJWRZZ Supportive Autosomal recessive [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate affects the expression of Histone-arginine methyltransferase METTL23 (METTL23). [3]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Histone-arginine methyltransferase METTL23 (METTL23). [4]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Histone-arginine methyltransferase METTL23 (METTL23). [5]
Temozolomide DMKECZD Approved Temozolomide increases the expression of Histone-arginine methyltransferase METTL23 (METTL23). [6]
Indomethacin DMSC4A7 Approved Indomethacin increases the expression of Histone-arginine methyltransferase METTL23 (METTL23). [7]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 increases the expression of Histone-arginine methyltransferase METTL23 (METTL23). [9]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Histone-arginine methyltransferase METTL23 (METTL23). [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Histone-arginine methyltransferase METTL23 (METTL23). [8]
------------------------------------------------------------------------------------

References

1 METTL23, a transcriptional partner of GABPA, is essential for human cognition. Hum Mol Genet. 2014 Jul 1;23(13):3456-66. doi: 10.1093/hmg/ddu054. Epub 2014 Feb 5.
2 Disruption of the methyltransferase-like 23 gene METTL23 causes mild autosomal recessive intellectual disability. Hum Mol Genet. 2014 Aug 1;23(15):4015-23. doi: 10.1093/hmg/ddu115. Epub 2014 Mar 13.
3 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
4 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
5 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
6 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
7 Mechanisms of indomethacin-induced alterations in the choline phospholipid metabolism of breast cancer cells. Neoplasia. 2006 Sep;8(9):758-71.
8 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
9 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
10 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.